Choon Chiat Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Choon Chiat Oh has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
Po Yin Tang
Department of Anatomical Pathology, Singapore General Hospital, Singapore
9 shared publicationsKok Hing Lim
6 shared publications- Shi Huan Tay
Department of Dermatology, Singapore General Hospital, Singapore 169608, Singapore
5 shared publications Inny Busmanis
Department of Anatomical Pathology, Singapore General Hospital, Singapore
4 shared publications- Wen Hao Tan
Department of Dermatology Singapore General Hospital Singapore Singapore
4 shared publications Li Houng Chen
Singapore Gen Hosp, Duke NUS Med Sch, Dept Dermatol, Singapore, Singapore
3 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by Elsevier in JAAD International
- Vol. 29, 15-24
Development and validation of an artificial intelligence model for basal cell carcinoma detection and section completeness assessment in Mohs micrographic surgery in an Asian cohort
- 4 September 2026
- Published by Elsevier in JAAD International
- Vol. 29, 15-24
Open AccessDevelopment and validation of an artificial intelligence model for basal cell carcinoma detection and section completeness assessment in Mohs micrographic surgery in an Asian cohort
- Open Access
- 13 August 2026
- Published by Elsevier in JID Innovations
- Vol. 6 (6) , 100526
Human papillomavirus E6/7 specific T-cell responses among Asian individuals with cutaneous squamous cell carcinoma
- 13 August 2026
- Published by Elsevier in JID Innovations
- Vol. 6 (6) , 100526
Open AccessHuman papillomavirus E6/7 specific T-cell responses among Asian individuals with cutaneous squamous cell carcinoma
- Open Access
- 31 July 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 77, 158-161
Squamous cell carcinoma in situ and syringocystadenocarcinoma papilliferum overlap in an Asian patient: A case report and review of the literature
- 31 July 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 77, 158-161
Open AccessSquamous cell carcinoma in situ and syringocystadenocarcinoma papilliferum overlap in an Asian patient: A case report and review of the literature
- Open Access
- 13 January 2026
- Published by MDPI AG in Dermatopathology
- Vol. 13 (1) , 6
Tumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma—A Systematic Review
Cutaneous squamous cell carcinoma (cSCC) is an immunogenic malignancy with variable immune infiltration and inconsistent responses to checkpoint blockade. Tumor-infiltrating lymphocytes (TILs) influence tumor progression and therapeutic outcome, yet their phenotypic and functional diversity across disease contexts remains incompletely understood. This review systematically characterizes the TIL landscape in human cSCC. Following PRISMA 2020 guidelines, PubMed and Embase were searched up to May 2025 and restricted to studies evaluating tumor-infiltrating lymphocytes in human cSCC, using the modified Newcatle–Ottawa score to assess risk of bias. Data were synthesized qualitatively given methodological heterogeneity. 48 studies met inclusion criteria. cSCCs exhibited dense CD3+ infiltrates composed of cytotoxic (CD8+GzmB+, Ki-67+, CD69+) and regulatory (FOXP3+, CCR4+) subsets. Higher CD8+ activity correlated with smaller tumors and longer disease-free survival, whereas FOXP3+ enrichment and TGF-β2 signaling promoted immune evasion. Immunosuppressed patients demonstrated diminished CD8+ density and clonality. Immune modulation with PD-1/PD-L1 blockade, imiquimod, HPV vaccination, or OX40 stimulation enhanced effector function. The cSCC immune microenvironment reflects a balance between cytotoxic and suppressive factors. Harmonizing multimodal immune profiling and integrating spatial context with systemic immune status may advance both prognostic stratification and therapeutic design.
- 13 January 2026
- Published by MDPI AG in Dermatopathology
- Vol. 13 (1) , 6
Open AccessTumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma—A Systematic Review
Cutaneous squamous cell carcinoma (cSCC) is an immunogenic malignancy with variable immune infiltration and inconsistent responses to checkpoint blockade. Tumor-infiltrating lymphocytes (TILs) influence tumor progression and therapeutic outcome, yet their phenotypic and functional diversity across disease contexts remains incompletely understood. This review systematically characterizes the TIL landscape in human cSCC. Following PRISMA 2020 guidelines, PubMed and Embase were searched up to May 2025 and restricted to studies evaluating tumor-infiltrating lymphocytes in human cSCC, using the modified Newcatle–Ottawa score to assess risk of bias. Data were synthesized qualitatively given methodological heterogeneity. 48 studies met inclusion criteria. cSCCs exhibited dense CD3+ infiltrates composed of cytotoxic (CD8+GzmB+, Ki-67+, CD69+) and regulatory (FOXP3+, CCR4+) subsets. Higher CD8+ activity correlated with smaller tumors and longer disease-free survival, whereas FOXP3+ enrichment and TGF-β2 signaling promoted immune evasion. Immunosuppressed patients demonstrated diminished CD8+ density and clonality. Immune modulation with PD-1/PD-L1 blockade, imiquimod, HPV vaccination, or OX40 stimulation enhanced effector function. The cSCC immune microenvironment reflects a balance between cytotoxic and suppressive factors. Harmonizing multimodal immune profiling and integrating spatial context with systemic immune status may advance both prognostic stratification and therapeutic design.
- Open Access
- 22 December 2025
- Published by Elsevier in JAAD Reviews
- Vol. 7, 61-69
Human papillomavirus and cutaneous squamous cell carcinoma: A review
- 22 December 2025
- Published by Elsevier in JAAD Reviews
- Vol. 7, 61-69
Open AccessHuman papillomavirus and cutaneous squamous cell carcinoma: A review
- Open Access
- 30 September 2025
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 18 (1) , 1-7
Trends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19
Skin disorders comprise a significant portion of emergency department (ED) visits. Limited dermatology training among junior ED doctors poses challenges, especially during crises like COVID-19, which introduced resource constraints and new viral rash morphologies. This study examines dermatological ED presentations at Singapore General Hospital, comparing pre-pandemic (2018–2019) and pandemic (2020–2021) trends in diagnosis and disposition patterns. A retrospective analysis of de-identified electronic health records (2018–2021) was conducted. Data included patient demographics, diagnosis, and disposition (admission, referral, discharge). Diagnoses were classified into major categories, and statistical analyses were performed using Python 3.12 and chi-squared tests. Among 28,621 cases, dermatological presentations declined by 15.6% during COVID-19. Infective conditions remained the most common, with bacterial cellulitis and herpes zoster leading. Inflammatory dermatoses, especially urticaria, atopic, and contact dermatitis, increased during the pandemic. Allergy cases surged in 2021, largely linked to COVID-19 vaccinations. Admissions peaked in 2020, and referrals to dermatologists increased in 2021, while GP referrals declined. Major shifts in dermatological ED trends highlight the impact of PPE usage, vaccinations, and pandemic psychological stressors. Increased admissions and specialist referrals emphasize the need for enhanced dermatology training and resource allocation in emergency medicine for future pandemic preparedness.
- 30 September 2025
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 18 (1) , 1-7
Open AccessTrends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19
Skin disorders comprise a significant portion of emergency department (ED) visits. Limited dermatology training among junior ED doctors poses challenges, especially during crises like COVID-19, which introduced resource constraints and new viral rash morphologies. This study examines dermatological ED presentations at Singapore General Hospital, comparing pre-pandemic (2018–2019) and pandemic (2020–2021) trends in diagnosis and disposition patterns. A retrospective analysis of de-identified electronic health records (2018–2021) was conducted. Data included patient demographics, diagnosis, and disposition (admission, referral, discharge). Diagnoses were classified into major categories, and statistical analyses were performed using Python 3.12 and chi-squared tests. Among 28,621 cases, dermatological presentations declined by 15.6% during COVID-19. Infective conditions remained the most common, with bacterial cellulitis and herpes zoster leading. Inflammatory dermatoses, especially urticaria, atopic, and contact dermatitis, increased during the pandemic. Allergy cases surged in 2021, largely linked to COVID-19 vaccinations. Admissions peaked in 2020, and referrals to dermatologists increased in 2021, while GP referrals declined. Major shifts in dermatological ED trends highlight the impact of PPE usage, vaccinations, and pandemic psychological stressors. Increased admissions and specialist referrals emphasize the need for enhanced dermatology training and resource allocation in emergency medicine for future pandemic preparedness.
- 27 September 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Tumour Infiltrating Lymphocytes in cutaneous Squamous Cell Carcinoma: A Protocol for Systematic Review
INPLASY202590114 Tumour Infiltrating Lymphocytes in cutaneous Squamous Cell Carcinoma: A Protocol for Systematic Review Keywords: Tumour Infiltrating Lymphocytes, cutaneous squamous cell carcinoma.…
- 27 September 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Tumour Infiltrating Lymphocytes in cutaneous Squamous Cell Carcinoma: A Protocol for Systematic Review
INPLASY202590114 Tumour Infiltrating Lymphocytes in cutaneous Squamous Cell Carcinoma: A Protocol for Systematic Review Keywords: Tumour Infiltrating Lymphocytes, cutaneous squamous cell carcinoma.…
- Open Access
- 3 September 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (5) , 1101-1113
Immunological and Viral Profiles of Squamous Cell Carcinoma in Transplant and Non‐Transplant Patients in Singapore
Background: Cutaneous squamous cell carcinoma (cSCC) remains poorly understood at the molecular level, both in the immunocompetent and immunosuppressed population with skin of colour. Data on the diversity of viruses found in cSCC is also lacking. Objectives: We aimed to characterise the immunological and molecular profiles of cSCC in organ transplant recipients (OTR) and non‐transplant recipients in an Asian cohort ( n = 53) and explore the diversity of viruses detected. Methods: Gene expression analysis was performed on snap‐frozen cSCC tissues using the NanoString PanCancer IO360 panel. Viral detection was performed using the Twist Comprehensive Viral Research Panel. Results: cSCC presented dysregulation of immune response pathways and tumour microenvironment remodelling compared to adjacent normal skin tissue. Cell‐type profiling based on gene expression profiles showed higher levels of exhausted CD8 cells, neutrophils, and cytotoxic cells in tumour cells. Furthermore, three distinct clusters of cSCC gene signatures could be observed, where Cluster 3 with the highest Tumour inflammation signature (TIS) scores displayed distinct upregulation of most pathways suggesting a more inflamed or “hot” tumour phenotype. cSCC of OTR exhibited greater expression of tumour markers ( AQP9 , SERPINA1 ) and reduced expression of T‐cell cytokines ( CXCL10 , CXCL11 ). Viruses were particularly enriched in tumour tissue, as compared with normal skin. In addition, there was an enrichment of detectable viruses in transplant‐associated cSCC, with several tumours harbouring multiple viruses (HPV, EBV, MCV, and TTV). Conclusions: cSCC is marked by a pro‐tumorigenic immune environment with altered immune cell populations. These findings support the potential for stratified, immune‐tailored treatment approaches for cSCC, especially in OTR who have a higher disease burden. Future studies on the possible oncogenic role of the detected viruses can be undertaken.
- 3 September 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (5) , 1101-1113
Open AccessImmunological and Viral Profiles of Squamous Cell Carcinoma in Transplant and Non‐Transplant Patients in Singapore
Background: Cutaneous squamous cell carcinoma (cSCC) remains poorly understood at the molecular level, both in the immunocompetent and immunosuppressed population with skin of colour. Data on the diversity of viruses found in cSCC is also lacking. Objectives: We aimed to characterise the immunological and molecular profiles of cSCC in organ transplant recipients (OTR) and non‐transplant recipients in an Asian cohort ( n = 53) and explore the diversity of viruses detected. Methods: Gene expression analysis was performed on snap‐frozen cSCC tissues using the NanoString PanCancer IO360 panel. Viral detection was performed using the Twist Comprehensive Viral Research Panel. Results: cSCC presented dysregulation of immune response pathways and tumour microenvironment remodelling compared to adjacent normal skin tissue. Cell‐type profiling based on gene expression profiles showed higher levels of exhausted CD8 cells, neutrophils, and cytotoxic cells in tumour cells. Furthermore, three distinct clusters of cSCC gene signatures could be observed, where Cluster 3 with the highest Tumour inflammation signature (TIS) scores displayed distinct upregulation of most pathways suggesting a more inflamed or “hot” tumour phenotype. cSCC of OTR exhibited greater expression of tumour markers ( AQP9 , SERPINA1 ) and reduced expression of T‐cell cytokines ( CXCL10 , CXCL11 ). Viruses were particularly enriched in tumour tissue, as compared with normal skin. In addition, there was an enrichment of detectable viruses in transplant‐associated cSCC, with several tumours harbouring multiple viruses (HPV, EBV, MCV, and TTV). Conclusions: cSCC is marked by a pro‐tumorigenic immune environment with altered immune cell populations. These findings support the potential for stratified, immune‐tailored treatment approaches for cSCC, especially in OTR who have a higher disease burden. Future studies on the possible oncogenic role of the detected viruses can be undertaken.
- Open Access
Electrochemotherapy in the Management of Keratinocyte Carcinomas: A Systematic Review
Background: Keratinocyte carcinomas, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), presents a growing concern. Electrochemotherapy (ECT), an emerging treatment modality, combines chemotherapy and electroporation to enhance drug delivery into cells. However, reviews evaluating ECT in keratinocyte carcinomas are lacking. Objectives: This study reviews the efficacy and toxicity of ECT in the treatment and palliation of keratinocyte carcinomas. Methods: A systematic search was conducted across PubMed, Cochrane, Embase, and Scopus databases. Patient, tumor, and treatment characteristics, tumor response, long-term disease outcomes, and toxicity data were extracted. Quality of studies was assessed using validated tools. Primary endpoints included tumor response; secondary endpoints included long-term disease outcomes and toxicity. Results: Twenty-one studies were included. Complete response (CR) rates ranged from 50 to 100% and from 10 to 100% for BCC and SCC, respectively. OS rates ranged from 95 (14 months) to 100 (1 year) % and from 64 (1 year) to 85.1 (8.6 months) % for BCC and SCC, respectively. One-year local disease-free survival (LDFS) rates were 89% and 87% for BCC and SCC, respectively. For BCC, local progression-free survival (LPFS) rates were 96% (1 year), 90% (2 year), and 70% (5 year). For SCC, 1-year LPFS rates were 80% on a per-patient basis and 49% on a per-lesion basis. Conclusions: ECT is effective and tolerable in the treatment and palliation of keratinocyte carcinomas. Future studies should focus on improving reporting quality, optimizing treatment protocols, and investigating long-term outcomes.
Open AccessElectrochemotherapy in the Management of Keratinocyte Carcinomas: A Systematic Review
Background: Keratinocyte carcinomas, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), presents a growing concern. Electrochemotherapy (ECT), an emerging treatment modality, combines chemotherapy and electroporation to enhance drug delivery into cells. However, reviews evaluating ECT in keratinocyte carcinomas are lacking. Objectives: This study reviews the efficacy and toxicity of ECT in the treatment and palliation of keratinocyte carcinomas. Methods: A systematic search was conducted across PubMed, Cochrane, Embase, and Scopus databases. Patient, tumor, and treatment characteristics, tumor response, long-term disease outcomes, and toxicity data were extracted. Quality of studies was assessed using validated tools. Primary endpoints included tumor response; secondary endpoints included long-term disease outcomes and toxicity. Results: Twenty-one studies were included. Complete response (CR) rates ranged from 50 to 100% and from 10 to 100% for BCC and SCC, respectively. OS rates ranged from 95 (14 months) to 100 (1 year) % and from 64 (1 year) to 85.1 (8.6 months) % for BCC and SCC, respectively. One-year local disease-free survival (LDFS) rates were 89% and 87% for BCC and SCC, respectively. For BCC, local progression-free survival (LPFS) rates were 96% (1 year), 90% (2 year), and 70% (5 year). For SCC, 1-year LPFS rates were 80% on a per-patient basis and 49% on a per-lesion basis. Conclusions: ECT is effective and tolerable in the treatment and palliation of keratinocyte carcinomas. Future studies should focus on improving reporting quality, optimizing treatment protocols, and investigating long-term outcomes.
- Open Access
- 9 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (10) , 1196
Editorial for “Latest Advances in Diagnosis and Management of Skin Cancer”
The rising global incidence of skin cancer has established this disease as a critical public health issue
- 9 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (10) , 1196
Open AccessEditorial for “Latest Advances in Diagnosis and Management of Skin Cancer”
The rising global incidence of skin cancer has established this disease as a critical public health issue